Professor Ray Hill

Following his academic training at the University of London, he was a lecturer in Pharmacology at the University of Bristol from 1974 to 1983 and supervisor in Pharmacology at Downing College, University of Cambridge from 1983 to 1988. He joined the pharmaceutical industry in 1983 as Head of Biology at the Park Davis Research Unit, Cambridge. In 1988 he joined Smith, Kline and French (UK) as Group Director, Pharmacology. From 1990 until his retirement in 2008 he worked in drug discovery research for Merck / MSD. He has been a Council Member of the British Pain Society, is President Emeritus, British Pharmacological Society and was a coopted Member of Council, Academy of Medical Sciences. He was a member of the ABPI R&D committee and was a member of the EFPIA Research Directors Group. He was a member of the Nuffield Council on Bioethics until 2013 and is a member of the Advisory Council on the Misuse of Drugs. He serves as a NED of Addex, Avilex, Asceneuron and Orexo.